MEET OUR BOARD
Carol McDaid serves as Principal at Capitol Decisions, Inc. Capitol Decisions has a special expertise in addiction and mental health policy. For over two decades, Ms. McDaid has worked with leading addiction and mental health provider and consumer organizations to refine public policy addressing addiction and mental health. With nearly 30 years of Federal legislative experience in Washington, Ms. McDaid provides clients with public affairs consulting on issues that span the breadth of health care, including behavioral health, Medicare, Medicaid, and private sector reimbursement issues. Ms. McDaid served as a strategist and advisor to the Parity NOW Coalition, which was influential in passage of the 2008 “Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act.” This landmark legislation requires insurers to treat addiction, mental, and physical health problems equally. To make a difference at the local level, in 2004, Ms. McDaid co-founded the McShin Foundation in Richmond, Virginia with her husband, John Shinholser. McShin is a leading non-profit, full-service recovery community organization committed to serving individuals and families in and seeking recovery from addiction in the State of Virginia. McShin offers peer-to-peer recovery support services that include recovery coaching, housing, and justice based recovery supports. Because Ms. McDaid personally struggled with addiction, she understands the challenges, political and personal, of dealing with alcohol and drug issues. She is a founding member of Faces and Voices of Recovery and is a board member of Young People in Recovery.
Neely Carlton Lyons
Neely Carlton Lyons draws from her public service and legal experience to finds ways to help others. As Senior Counsel at Butler Snow, she assists addiction and mental health treatment providers, advises corporations and healthcare entities regarding wellness and early intervention policies, and advocates for community-based recovery resources. Mrs. Lyons is a trained interventionist who speaks nationally and volunteers her time to coalitions engaging policy makers and the public. She is a former state senator who has received numerous civic awards including the Mississippi Business Journal’s 2017 Healthcare Hero Award.
Ben A. Guill
Ben A. Guill is managing partner and co-founder of White Deer Energy, an investment firm with offices in Houston and New York. During that period, he helped the firm and the funds it raised grow from $812 million with seven investment professionals to $7.8 billion with 35 investment professionals. Mr. Guill managed First Reserve’s Houston office, focusing on deal origination, investment analysis, negotiation of acquisitions and management of portfolio companies.
Prior to 1998, he was Co-Head of Investment Banking at Simmons & Company International, a leading specialized investment bank serving the energy industry. Mr. Guill joined Simmons in 1980 and served 19 years in corporate finance, working primarily on mergers and acquisitions, financings and corporate restructuring. Prior to his service with Simmons, he was an Associate at Blyth Eastman Dillon.
Mr. Guill is currently a Director of National Oilwell Varco (NYSE:NOV). He serves on the Board of MD Anderson Cancer Center in Houston and the Houston region of Teach for America. Mr. Guill holds an MBA in Finance from Wharton School and a BA in English from Princeton University.
Jeff Olivet, M.A.
Jeff Olivet is the President/CEO of the Boston-based Center for Social Innovation. For more than two decades, Jeff has been a national leader on homelessness, poverty, affordable housing, behavioral health, public health, and HIV. During his health and human services career, he has been a street outreach worker, case manager, housing director, coalition builder, writer, teacher, and activist. His work with hundreds of organizations across the United States and internationally has helped to improve strategic planning, organizational management, and implementation of evidence-based practices. Jeff is recognized as an expert in bringing innovative technologies and solutions to complex social problems.
Levenson strives to improve the lives of millions of individuals and families. He has established MAP as the nation’s leader in the provision of tech-enabled PEER and professional services to improve clinical and financial treatment outcomes for healthcare plans, treatment providers, and healthcare consumers. MAP is driven to optimize the care continuum and its data suggests that this is the foundation for improving healthcare delivery in this country. Levenson is also a Board Member at The Levenson Foundation and a founding member of Tri-Private Capital.
Steve Sost serves as VP, Internal Communications, at Impax Laboratories, where he brings more than 15 years of experience in M&A communications, global branding; internal communications; and employee culture design and engagement. Most recently, Steve served as Global Lead, Employee Engagement, at Merck. Prior to Merck, Steve spent six years at Allergan (previously known as Actavis) as Executive Director, Corporate Communications, where he led global internal communications and spearheaded the company’s commitment to addiction awareness. Steve also spent considerable time as a partner with Mayr Communications, a strategic communications firm, advising various organizations, including the Generic Pharmaceutical Association (GPhA). Steve received his B.A. degree from Marist College.
As an early supporter and champion of YPR, Charlie Mayr is remembered by YPR as a memorial board member in perpetuity so his spirit, love of life and passion for our cause will always be with us. Mayr was appointed Chief Communications Officer of Actavis on April 27, 2012. Charlie joined Watson as Senior Vice President, Corporate Affairs in September 2009. Prior to joining Watson, Charlie operated an advertising and public relations consulting company from 1998 to 2009, serving such clients as Watson, the Generic Pharmaceutical Association (GPhA), Barr Pharmaceuticals and a variety of professional associations and consumer products and service companies. Prior to starting his consultancy business, he served as Director of Corporate Communications for Barr Pharmaceuticals, Inc. from 1994 to 1998. Prior to joining Barr, he served as Director of Global Communications from 1990 to 1994 for Sterling Drug Inc., the global brand and consumer health products pharmaceutical subsidiary of Kodak. Charlie began his career as a broadcast and print journalist and received a B.A. in journalism from New York University.